GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Days Payable

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Days Payable : 84.69 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Days Payable?

Hainan Huluwa Pharmaceutical Group Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥209 Mil. Hainan Huluwa Pharmaceutical Group Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥225 Mil. Hence, Hainan Huluwa Pharmaceutical Group Co's Days Payable for the three months ended in Mar. 2024 was 84.69.

The historical rank and industry rank for Hainan Huluwa Pharmaceutical Group Co's Days Payable or its related term are showing as below:

SHSE:605199' s Days Payable Range Over the Past 10 Years
Min: 67.76   Med: 123.06   Max: 174.8
Current: 86.18

During the past 8 years, Hainan Huluwa Pharmaceutical Group Co's highest Days Payable was 174.80. The lowest was 67.76. And the median was 123.06.

SHSE:605199's Days Payable is ranked worse than
51.28% of 975 companies
in the Drug Manufacturers industry
Industry Median: 88.64 vs SHSE:605199: 86.18

Hainan Huluwa Pharmaceutical Group Co's Days Payable increased from Mar. 2023 (72.64) to Mar. 2024 (84.69). It may suggest that Hainan Huluwa Pharmaceutical Group Co delayed paying its suppliers.


Hainan Huluwa Pharmaceutical Group Co Days Payable Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Days Payable Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial 121.65 124.47 101.80 82.61 67.76

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 72.64 107.19 94.63 58.81 84.69

Competitive Comparison of Hainan Huluwa Pharmaceutical Group Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Hainan Huluwa Pharmaceutical Group Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hainan Huluwa Pharmaceutical Group Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hainan Huluwa Pharmaceutical Group Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Hainan Huluwa Pharmaceutical Group Co's Days Payable falls into.



Hainan Huluwa Pharmaceutical Group Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Hainan Huluwa Pharmaceutical Group Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (139.917 + 194.162) / 2 ) / 899.832*365
=167.0395 / 899.832*365
=67.76

Hainan Huluwa Pharmaceutical Group Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (194.162 + 223.124) / 2 ) / 224.817*365 / 4
=208.643 / 224.817*365 / 4
=84.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hainan Huluwa Pharmaceutical Group Co Days Payable Related Terms

Thank you for viewing the detailed overview of Hainan Huluwa Pharmaceutical Group Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Traded in Other Exchanges
N/A
Address
No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300
Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines